GF Fund Management’s AnaptysBio ANAB Stock Holding History

GF Fund Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.9K	Sell	576 -45	-7%	-$2.73K	﹤0.01%	422
2026 Q1	$34.4K	Buy	621 +78	+14%	+$4.2K	﹤0.01%	443
2025 Q4	$26.3K	Sell	543 -59	-10%	-$2.3K	﹤0.01%	476
2025 Q3	$18.4K	Sell	602 -177	-23%	-$4.06K	﹤0.01%	501
2025 Q2	$17.3K	Hold	779	–	–	﹤0.01%	515
2025 Q1	$14.5K	Buy	779 +140	+22%	+$2.34K	﹤0.01%	525
2024 Q4	$8.46K	Buy	+639	New	+$15.5K	﹤0.01%	569

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

GF Fund Management's ANAB Position: Q2 2026 in Review

GF Fund Management reduced its AnaptysBio (ANAB) stake by 7.2% in Q2 2026, selling an estimated $2.73K and leaving 576 shares worth $38.9K. The position accounts for ﹤0.01% of the portfolio, ranked #422.

GF Fund Management first reported a position in ANAB in Q4 2024 and has held it in 7 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

GF Fund Management held 576 shares of AnaptysBio worth $38.9K as of Q2 2026.
GF Fund Management sold 45 AnaptysBio shares in Q2 2026, an estimated $2.73K.
AnaptysBio made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #422 holding.
GF Fund Management first reported a position in AnaptysBio in Q4 2024 and has held it in 7 quarters since.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.